Access to Artemisinin-Combination Therapy (ACT) and other Anti-Malarials: National Policy and Markets in Sierra Leone

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Amuasi, John H ^a,b   Diap, Graciela ^c   Nguah, Samuel Blay ^b   Karikari, Patrick ^b   Boakye, Isaac ^b   Jambai, Amara ^d   Lahai, Wani Kumba ^d   Louie, Karly S ^e   Kiechel, Jean Rene ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

^c Drugs for Neglected Diseases initiative DNDi   (Switzerland)

^d MINISTRY OF HEALTH AND SANITATION   (Sierra Leone)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; AMODIAQUINE PLUS ARTESUNATE; ANTIMALARIAL AGENT; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; ARTESUNATE; ARTESUNATE PLUS MEFLOQUINE; CHLOROQUINE; HALOFANTRINE; MEFLOQUINE; PROGUANIL; PYRIMETHAMINE; PYRIMETHAMINE PLUS SULFADOXINE; QUININE;

ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CROSS-SECTIONAL STUDY; DRUG COST; DRUG MARKETING; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; RURAL AREA; SIERRA LEONE; URBAN AREA;

AMODIAQUINE; ANTIMALARIALS; ARTEMISININS; DRUG COSTS; GEOGRAPHY; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALARIA; ORGANIZATIONS, NONPROFIT; PHARMACIES; POVERTY; PRIVATE SECTOR; PUBLIC SECTOR; SIERRA LEONE;

ARTESUNATE; PLASMODIUM FALCIPARUM;

EID: 84868128321     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047733     Document Type: Article

References (25)

1. United Nations Development Program (2009) Human Development Report 2009. Available: http://hdr.undp.org/en/media/HDR_2009_EN_Complete.pdf. Accessed 25 March 2012.
2. World Health Organization (2010) World Malaria Report 2010. Geneva, Switzerland. Available: http://whqlibdoc.who.int/publications/2010/9789241564106_eng.pdf. Accessed 25 March 2012.
3. Ministry of Health and Sanitation Government of Sierra Leone (2005) National Malaria Control Programme: National Malaria Control Policy Document.
4. Checchi F, Roddy P, Kamara S, Williams A, Morineau G, et al. (2005) Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine. Trop Med Int Health 10: 146-153.
5. World Health Organization. Country Antimalarial Drug Policies: By Region. Available: http://www.who.int/malaria/am_drug_policies_by_region_afro/en/index.html. Accessed 25 March 2012.
6. Medecins Sans Frontieres Holland and Belgium (2008) Full Prescription: Better Malaria Treatment For More People, MSF's Experience. Brussels, Belgium: Medecins Sans Frontieres. Available: http://www.msf.org/source/medical/malaria/2008/MSF_malaria_2008.pdf. Accessed 25 March 2012.
7. World Health Organization (2009) World Malaria Report 2009: Annexes 5 and 6. Geneva, Switzerland. Available: http://whqlibdoc.who.int/publications/2009/9789241563901_eng.PDF. Accessed 25 March 2012.
8. Diap G, Amuasi J, Boakye I, Sevcsik AM, Pecoul B, (2010) Anti-malarial market and policy surveys in sub-Saharan Africa. Malar J 9Suppl 1: S1.
9. McGinnis M (2011) Media Reports on Medicine Quality: Focusing on USAID-assisted Countries. United States Pharmacopeia. Available: http://www.usp.org/sites/default/files/usp_pdf/EN/PQM/pqm-media-reports.pdf. Accessed 25 March 2012. Accessed 25 March 2012.
10. World Health Organization and Health Action International (2008) Measuring medicine prices, availability, affordability and price components, 2nd Edition. Geneva, Switzerland. Available: http://www.who.int/medicines/areas/access/medicines_prices08/en/index.html. Accessed 25 March 2012.
11. World Bank (2009) World Bank Indicators database:Gross national income per capita 2008, Atlas Method and Purchasing Power Parity. Washington, DC. Available: http://data.worldbank.org/sites/default/files/wdi08.pdf. Accessed 25 March 2012.
12. ACTwatch (2008) Baseline Outlet Survey Report, The Democratic Republic of the Congo Sept 2008-Nov 2008. Nairobi, Kenya: ACTwatch, Malaria Control & Child Survival Department. Available: http://www.actwatch.info/downloads/results/DRC%20Outlet%20Baseline,%20ACTwatch%2012-09.pdf. Accessed 25 March 2012.
13. Amuasi JH, Diap G, Blay-Nguah S, Boakye I, Karikari PE, et al. (2011) Access to artesunate-amodiaquine, quinine and other anti-malarials: policy and markets in Burundi. Malar J 10: 34.
14. Newton PN, Green MD, Dallas MC, Plançon A, Nettey H, et al. (2011) Poor quality vital anti-malarials in Africa- an urgent neglected public health priority. Malaria Journal 10: 352.
15. WHO Regional Office for Africa (2009) WHO Country Cooperation Strategy, 2008-20013- Sierra Leone. Brazaville, Republic of Congo. Available: http://www.who.int/countryfocus/cooperation_strategy/ccs_sle_en.pdf. Accessed 25 March 2012.
16. Sabot O, Yeung S, Pagnoni F, Gordon M, Petty N, et al. (2009) A Discussion Paper: Distribution of Artemisinin-Based Combination Therapies Through Private Sector Channels- Lessons from Four Country Case Studies. Washington, DC. Available: http://www.rff.org/RFF/Documents/RFF-DP-08-43_FINAL.pdf. Accessed 25 March 2012.
17. Ensor T, Lievens T, Naylor M (2008) Review of Financing of Health in Sierra Leone and the Development of Policy Options. Oxford Policy Management. Available: http://www.opml.co.uk/sites/opml/files/Review%20of%20Financing%20of%20Health%20in%20Sierra%20Leone%20150708.pdf. Accessed 25 March 2012.
18. Ministry of Health and Sanitation Government of Sierra Leone (2007) Republic of Sierra Leone National Health Accounts. Available: http://www.iiste.org/Journals/index.php/RJFA/article/download/190/74. Accessed 25 March 2012.
19. O'Connell K, On behalf of the ACTwatch group (2009) Availability, Volumes, Price and Use of Antimalarials in 7 Malaria Endemic Countries. Nairobi, Kenya: ACTwatch. Available: http://www.actwatch.info/downloads/results/7%20Country%20OS1%20and%204%20Country%20HH1%20Results,%20MIM%20Symposium,%20O%27Connell,%2003-11-09_FINAL.pdf. Accessed 25 March 2012.
20. Adeyi O, Atun R, (2010) Universal access to malaria medicines: innovation in financing and delivery. Lancet 376: 1869-1871.
21. World Health Organization (2010) Global Report on Antimalarial Drug Efficacy and Drug Resistance: 2000-2010. Geneva, Switzerland: World Health Organization. Available: http://whqlibdoc.who.int/publications/2010/9789241500470_eng.pdf. Accessed 25 March 2012.
22. Gelband H, Seiter A, (2007) A global subsidy for antimalarial drugs. Am J Trop Med Hyg 77: 219-221.
23. Abuya T, Amin A, Molyneux S, Akhwale W, Marsh V, et al. (2010) Importance of strategic management in the implementation of private medicine retailer programmes: case studies from three districts in Kenya. BMC Health Serv Res 10Suppl 1: S7.
24. Abuya TO, Fegan G, Amin AA, Akhwale WS, Noor AM, et al. (2010) Evaluating different dimensions of programme effectiveness for private medicine retailer malaria control interventions in Kenya. PLoS One 5: e8937.
25. Rowa Y, Abuya TO, Mutemi WK, Ochola S, Molyneux S, et al. (2010) Factors influencing implementation of the Ministry of Health-led private medicine retailer programmes on malaria in Kenya. BMC Public Health 10: 93.